The FDA is reporting that Gardisil, a vaccine that prevents certain strains of HPV, "is effective in preventing male genital warts 90% of the time." Talk of supplying the drug to males is being highly considered and supposedly was reviewed this week."According to documents posted online, the vaccine blocks two strains of HPV that cause irregular growths and rare types of cancer in male genitals. A panel of experts will consider Merck's appeal for approval of the vaccine for use in boys ages nine to 26" - AP
Read Full Story: MedicalNewsToday
0 comments:
Post a Comment